Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Alison Lesley Lee has worked on the following 6 EPO patent applications which have been published in the last five years:

EP12723206

BCMA (CD269/TNFRSF17) -BINDING PROTEINS

IPC classification:
A61K 47/48, C07K 16/28
Applicant:
Glaxo Group Limited
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP13750350

ANTI LRP6 ANTIBODIES

IPC classification:
C07K 16/28
Applicant:
Glaxo Group Limited
Agent:
Alison Lesley Lee, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14703286

TNF-ALPHA ANTIGEN-BINDING PROTEINS

IPC classification:
A61K 39/395, C07K 16/24
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Alison Lesley Lee, GlaxoSmithKline
Status:
GRANT OF PATENT INTENDED
EP15197750

LIQUID FORMULATION COMPRISING ADALIMUMAB AND AN ACETATE BUFFER

IPC classification:
C07K 16/24
Applicant:
Glaxo Group Limited
Agent:
Alison Lesley Lee, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP15724070

ANTIBODY FORMULATION

IPC classification:
A61K 39/395, C07K 16/28
Agent:
Alison Lesley Lee, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP16183212

CYTOTOXIC ANTI-LAG-3 MONOCLONAL ANTIBODY AND ITS USE IN THE TREATMENT OR PREVENTION OF ORGAN TRANSPLANT REJECTION AND AUTOIMMUNE DISEASE

IPC classification:
A61K 39/00, C07K 16/28, C12N 5/0783
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Alison Lesley Lee, GlaxoSmithKline
Status:
Request for examination was made

Please Sign in to use this feature